These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
3. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis. Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424 [TBL] [Abstract][Full Text] [Related]
4. Prognosis and survival after radical resection of primary adenosquamous lung carcinoma. Gawrychowski J; Bruliński K; Malinowski E; Papla B Eur J Cardiothorac Surg; 2005 Apr; 27(4):686-92. PubMed ID: 15784375 [TBL] [Abstract][Full Text] [Related]
5. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872 [TBL] [Abstract][Full Text] [Related]
6. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy. Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588 [TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of primary lung cancer with synchronous brain metastases. Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience. Sarkaria IS; Iyoda A; Roh MS; Sica G; Kuk D; Sima CS; Pietanza MC; Park BJ; Travis WD; Rusch VW Ann Thorac Surg; 2011 Oct; 92(4):1180-6; discussion 1186-7. PubMed ID: 21867986 [TBL] [Abstract][Full Text] [Related]
9. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related]
10. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis. Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901 [TBL] [Abstract][Full Text] [Related]
11. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
12. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution. Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Asoh H; Yamaguchi M; Yoshino I; Ichinose Y J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711 [TBL] [Abstract][Full Text] [Related]
14. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension. Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471 [TBL] [Abstract][Full Text] [Related]
15. Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker. Sayar A; Turna A; Solak O; Kiliçgün A; Urer N; Gürses A Ann Thorac Surg; 2004 Feb; 77(2):421-5. PubMed ID: 14759409 [TBL] [Abstract][Full Text] [Related]
16. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Bischof M; Debus J; Herfarth K; Muley T; Kappes J; Storz K; Hoffmann H Strahlenther Onkol; 2007 Dec; 183(12):679-84. PubMed ID: 18040612 [TBL] [Abstract][Full Text] [Related]
17. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805 [TBL] [Abstract][Full Text] [Related]
18. Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial. Bennouna J; Senellart H; Hiret S; Vaissiere N; Douillard JY Lung Cancer; 2011 Oct; 74(1):30-4. PubMed ID: 21371774 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study. Sanpaolo P; Barbieri V; Genovesi D Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742 [TBL] [Abstract][Full Text] [Related]
20. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]